"Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".

Rates of de novo or secondary cancers are elevated in both SOT and HSCT compared with the general population and mainly for skin and haematological cancers. Among transplant recipients, older age and current elevated CRP are risk factors.